KR19990062986A - 경피 흡수형 제제 - Google Patents
경피 흡수형 제제 Download PDFInfo
- Publication number
- KR19990062986A KR19990062986A KR1019980054329A KR19980054329A KR19990062986A KR 19990062986 A KR19990062986 A KR 19990062986A KR 1019980054329 A KR1019980054329 A KR 1019980054329A KR 19980054329 A KR19980054329 A KR 19980054329A KR 19990062986 A KR19990062986 A KR 19990062986A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- plaster layer
- weight
- meth
- adhesive
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title abstract description 55
- 238000009472 formulation Methods 0.000 title abstract description 41
- 239000011505 plaster Substances 0.000 claims abstract description 72
- 230000001070 adhesive effect Effects 0.000 claims abstract description 54
- 239000000853 adhesive Substances 0.000 claims abstract description 42
- 238000002360 preparation method Methods 0.000 claims abstract description 39
- YREYLAVBNPACJM-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol Chemical compound CC(C)(C)NCC(O)C1=CC=CC=C1Cl YREYLAVBNPACJM-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229960000859 tulobuterol Drugs 0.000 claims abstract description 36
- -1 polyoxyethylene Polymers 0.000 claims description 35
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 33
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 229920001971 elastomer Polymers 0.000 claims description 20
- 239000005060 rubber Substances 0.000 claims description 20
- 229920000642 polymer Polymers 0.000 claims description 19
- 239000000654 additive Substances 0.000 claims description 18
- 229920002367 Polyisobutene Polymers 0.000 claims description 17
- 239000000178 monomer Substances 0.000 claims description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 239000003522 acrylic cement Substances 0.000 claims description 12
- 125000006353 oxyethylene group Chemical group 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 150000004665 fatty acids Chemical class 0.000 claims description 8
- 125000000524 functional group Chemical group 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 150000005215 alkyl ethers Chemical class 0.000 claims description 5
- 229920006132 styrene block copolymer Polymers 0.000 claims description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- 125000003368 amide group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 3
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 claims description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical group CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 39
- 239000003814 drug Substances 0.000 abstract description 39
- 239000013078 crystal Substances 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 238000001556 precipitation Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 66
- 239000000243 solution Substances 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 20
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229920006243 acrylic copolymer Polymers 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 5
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 5
- 125000002723 alicyclic group Chemical group 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920002114 octoxynol-9 Polymers 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 230000036765 blood level Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229920006267 polyester film Polymers 0.000 description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 2
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- 229920004939 Cariflex™ Polymers 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000011086 glassine Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000005011 phenolic resin Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001228 polyisocyanate Polymers 0.000 description 2
- 239000005056 polyisocyanate Substances 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- YDCNQCBHXZBLPP-UHFFFAOYSA-N 2-aminoacetic acid;octanoic acid Chemical compound NCC(O)=O.CCCCCCCC(O)=O YDCNQCBHXZBLPP-UHFFFAOYSA-N 0.000 description 1
- IYVVKFYDGRJWTR-UHFFFAOYSA-N 2-decanoylglycerol Chemical compound CCCCCCCCCC(=O)OC(CO)CO IYVVKFYDGRJWTR-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- LFIVUPGZYYBPKC-UHFFFAOYSA-N 3,4-dihydro-2h-chromene;1h-indene Chemical compound C1=CC=C2CC=CC2=C1.C1=CC=C2CCCOC2=C1 LFIVUPGZYYBPKC-UHFFFAOYSA-N 0.000 description 1
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical group CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 239000002174 Styrene-butadiene Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000005264 electron capture Effects 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 239000011115 styrene butadiene Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- XOALFFJGWSCQEO-UHFFFAOYSA-N tridecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C=C XOALFFJGWSCQEO-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
접착제 | 첨가제 | 약물 함량 | 약물 상태 | |
실시예 1 | 아크릴 공중합체 | 없음 | 10% | 용해된 상태 |
실시예 2 | 아크릴 공중합체 | 폴리옥시에틸렌 옥틸페닐 에테르 10% | 10% | 용해된 상태 |
실시예 3 | 아크릴 공중합체 | 이소프로필미리스테이트 30% | 20% | 용해된 상태 |
실시예 4 | 아크릴 공중합체 | 이소프로필 미리스테이트 40%, 글리세린 모노카프릴레이트 5% | 10% | 용해된 상태 |
실시예 5 | 고무 중합체(폴리이소부틸렌) | 이소프로필미리스테이트 40% | 5% | 용해된 상태 |
실시예 6 | 고무 중합체(폴리이소부틸렌) | 디이소프로필아디페이트 30% | 5% | 용해된 상태 |
실시예 7 | 고무 중합체(SBS) | 이소프로필미리스테이트 40% | 5% | 용해된 상태 |
실시예 8 | 고무 중합체(SIS/폴리이소부틸렌) | 이소프로필미리스테이트 40% | 5% | 용해된 상태 |
비교예 1 | 아크릴 공중합체 | 없음 | 10% | 결정의 분산액 |
비교예 2 | 고무 중합체(폴리이소프렌) | 이소프로필미리스테이트 40% | 5% | 결정의 분산액 |
접 착 력(g/ 12 mm) | ||
초 기 | 40℃, 1 개월 | |
실시예 1 | 546 | 554 |
실시예 2 | 413 | 408 |
실시예 3 | 78 | 82 |
실시예 4 | 66 | 63 |
실시예 5 | 48 | 52 |
실시예 6 | 58 | 55 |
실시예 7 | 61 | 58 |
실시예 8 | 64 | 60 |
비교예 1 | 519 | 364 |
비교예 2 | 57 | 21 |
방 출 율(%) | ||||||
초 기 | 40℃, 1 개월 | |||||
3 시간 | 8 시간 | 24 시간 | 3 시간 | 8 시간 | 24 시간 | |
실시예 1 | 62.1 | 91.4 | 98.6 | 60.9 | 91.2 | 98.2 |
실시예 5 | 47.6 | 74.7 | 93.9 | 45.8 | 75.3 | 95.1 |
비교예 1 | 54.7 | 82.1 | 96.2 | 35.3 | 53.6 | 81.0 |
비교예 2 | 39.8 | 56.4 | 82.3 | 30.1 | 45.3 | 72.2 |
Claims (8)
- 지지체 및 이 지지체 상에 적층되어 있는 플라스터 층을 포함하며, 상기 플라스터 층이 용해된 상태에서 5 중량% 이상의 비율인 툴로부테롤과 접착제를 포함하는 것인 경피 흡수형 제제.
- 제1항에 있어서, 상기 접착제가 아크릴 접착제 또는 고무 접착제인 경피 흡수형 제제.
- 제2항에 있어서, 상기 아크릴 접착제가 알킬기의 탄소 원자 수가 4 내지 12인 알킬(메타)아크릴레이트로 구성된 중합체를 50 중량% 이상의 비율로 포함하는 것인 경피 흡수형 제제.
- 제2항에 있어서, 상기 아크릴 접착제가 알킬기의 탄소 원자 수가 4 내지 12인 알킬(메타)아크릴레이트로 구성된 중합체를 60 중량% 이상 내지 98 중량%의 비율로, 그리고 분자 내에 1개 이상의 불포화 이중 결합과 측쇄 상의 작용기를 가진 작용기 단량체를 2 중량% 내지 40 중량%의 비율로 포함하는 것인 경피 흡수형 제제.
- 제4항에 있어서, 상기 작용기 단량체의 작용기가 카르복실기, 히드록실기, 술폰산기, 아미노기, 아미도기, 알콕시기, 시아노기 및 아실옥시기로 이루어진 군으로부터 선택되는 것 중에 하나인 경피 흡수형 제제.
- 제4항에 있어서, 상기 작용기 단량체가 (메타)아크릴산, 2-히드록시에틸 (메타)아크릴레이트, 스티렌술폰산, (메타)아크릴아미드, 비닐 피롤리돈, 2-아미노에틸 (메타)아크릴레이트, 아크릴로니트릴, 2-메톡시에틸 (메타)아크릴레이트 및 비닐 아세테이트로 이루어진 군으로부터 선택되는 것 중에 하나인 경피 흡수형 제제.
- 제2항에 있어서, 상기 고무 접착제가 폴리이소부틸렌 및 스티렌-디엔-스티렌 블록 공중합체로 이루어진 군으로부터 선택되는 1종 이상의 중합체를 포함하는 것인 경피 흡수형 제제.
- 제1항 내지 제7항 중 어느 하나의 항에 있어서, 상기 플라스터 층이 탄소 원자 수가 12 내지 16인 지방산의 에스테르, 탄소 원자 수가 8 내지 10인 지방산의 모노글리세라이드, 탄소 원자 수가 6 내지 10인 2염기성 산의 에스테르, 옥시에틸렌의 부가 몰수가 2 내지 5인 폴리옥시에틸렌 알킬 에테르 및 옥시에틸렌의 부가 몰수가 2 내지 5인 폴리옥시에틸렌 알킬페닐 에테르로 이루어진 군으로부터 선택되는 1종 이상의 첨가제를 5 중량% 내지 50 중량%의 비율로 더 포함하는 것인 경피 흡수형 제제.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP97-342582 | 1997-12-12 | ||
JP34258297 | 1997-12-12 | ||
JP98-304498 | 1998-10-26 | ||
JP30449898A JP3930984B2 (ja) | 1997-12-12 | 1998-10-26 | 経皮吸収型製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19990062986A true KR19990062986A (ko) | 1999-07-26 |
KR100610185B1 KR100610185B1 (ko) | 2006-11-30 |
Family
ID=26563935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980054329A KR100610185B1 (ko) | 1997-12-12 | 1998-12-11 | 경피흡수형제제 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6117447A (ko) |
EP (1) | EP0922453B1 (ko) |
JP (1) | JP3930984B2 (ko) |
KR (1) | KR100610185B1 (ko) |
CN (1) | CN1129426C (ko) |
AT (1) | ATE305775T1 (ko) |
BR (1) | BR9806470B1 (ko) |
CA (1) | CA2255447C (ko) |
DE (1) | DE69831785T2 (ko) |
DK (1) | DK0922453T3 (ko) |
ES (1) | ES2246062T3 (ko) |
HK (1) | HK1022091A1 (ko) |
HU (1) | HU227974B1 (ko) |
PL (1) | PL194195B1 (ko) |
PT (1) | PT922453E (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100439659B1 (ko) * | 2001-06-23 | 2004-07-12 | 제일약품주식회사 | 툴로부테롤을 함유하는 경피흡수용 패취제 |
KR100535302B1 (ko) * | 2002-02-01 | 2005-12-08 | 주식회사 태평양 | 툴로부테롤 함유 경피흡수형 제제 |
KR100956023B1 (ko) * | 2007-09-28 | 2010-05-06 | 대화제약 주식회사 | 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제 |
KR101014074B1 (ko) * | 1999-10-16 | 2011-02-14 | 에르테에스 로만 테라피-시스테메 아게 | 기관지확장제 튜로부테롤의 경피투여를 위한 튜로부테롤 염산염을 함유하는 경피 치료 시스템 |
KR20110109995A (ko) * | 2010-03-30 | 2011-10-06 | 닛토덴코 가부시키가이샤 | 패치 제제 및 이의 제조 방법 |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3930984B2 (ja) * | 1997-12-12 | 2007-06-13 | 日東電工株式会社 | 経皮吸収型製剤 |
JP3711846B2 (ja) * | 2000-07-27 | 2005-11-02 | 株式会社村田製作所 | 高周波モジュール及びそれを用いた移動体通信装置 |
DE60039726D1 (de) * | 2000-12-29 | 2008-09-11 | Martin Francis Gannon | Tiernahrungsmittelzusammensetzung |
KR100469995B1 (ko) * | 2002-05-20 | 2005-02-05 | 안국약품 주식회사 | 천식치료제를 함유한 매트릭스형 패취 |
JP2004224701A (ja) * | 2003-01-17 | 2004-08-12 | Yuutoku Yakuhin Kogyo Kk | 外用貼付剤 |
JP2004224741A (ja) * | 2003-01-23 | 2004-08-12 | Hisamitsu Pharmaceut Co Inc | ツロブテロール経皮吸収型製剤 |
JP4617069B2 (ja) * | 2003-06-16 | 2011-01-19 | コスメディ製薬株式会社 | 貼付剤 |
WO2004112770A1 (ja) | 2003-06-20 | 2004-12-29 | Teikoku Seiyaku Co., Ltd. | ツロブテロール含有貼付剤 |
EP1685830A4 (en) * | 2003-11-21 | 2010-04-28 | Sekisui Chemical Co Ltd | PLASTER |
CN1297257C (zh) * | 2004-01-02 | 2007-01-31 | 上海现代药物制剂工程研究中心有限公司 | 含有妥洛特罗的压敏胶,透皮贴剂及制备方法和应用 |
WO2005067910A1 (ja) * | 2004-01-20 | 2005-07-28 | Saitama Daiichi Pharmaceutical Co., Ltd. | ツロブテロール貼付剤 |
KR100579721B1 (ko) | 2004-09-15 | 2006-05-15 | (주) 에프디엘 | 툴로부테롤을 함유하는 경피투여용 패취제 |
JP2006206471A (ja) * | 2005-01-26 | 2006-08-10 | Nitto Denko Corp | テープ製剤 |
US7700659B2 (en) | 2005-03-24 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Implantable devices formed of non-fouling methacrylate or acrylate polymers |
US9381279B2 (en) | 2005-03-24 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Implantable devices formed on non-fouling methacrylate or acrylate polymers |
JP5058531B2 (ja) * | 2005-09-09 | 2012-10-24 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP4945228B2 (ja) | 2005-12-13 | 2012-06-06 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
AU2008221861B2 (en) * | 2007-03-08 | 2013-03-21 | Nitto Denko Corporation | Device for the transdermal administration of bisoprolol |
JP2009286707A (ja) * | 2008-05-27 | 2009-12-10 | Nitto Denko Corp | 医療材料又は衛生材料用のゲル組成物、その成形体及びそれを用いた貼付材もしくは貼付製剤 |
JP5432614B2 (ja) | 2008-07-17 | 2014-03-05 | 日東電工株式会社 | 貼付剤および貼付製剤 |
JP5432613B2 (ja) * | 2008-07-17 | 2014-03-05 | 日東電工株式会社 | 貼付剤および貼付製剤 |
JP2010241746A (ja) * | 2009-04-07 | 2010-10-28 | Nitto Denko Corp | 貼付剤および貼付製剤 |
JP5404145B2 (ja) * | 2009-04-10 | 2014-01-29 | 日東電工株式会社 | 貼付剤および貼付製剤 |
EP2667861A4 (en) * | 2011-01-26 | 2014-07-16 | Csi Gmbh | TRANSDERMAL PROLONGED RELEASE PATCHES ASSOCIATING A BETA-AGONIST AND ANTICHOLINERGIC AND METHODS OF USE |
WO2012103015A2 (en) * | 2011-01-27 | 2012-08-02 | Csi Gmbh | Extended-release beta agonist/steroid transdermal patches and methods for using the same |
CN103127032A (zh) * | 2011-11-30 | 2013-06-05 | 大化制药株式会社 | 妥洛特罗贴剂 |
JP6757351B2 (ja) | 2017-04-28 | 2020-09-16 | 日東電工株式会社 | 経皮吸収型製剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5300291A (en) * | 1988-03-04 | 1994-04-05 | Noven Pharmaceuticals, Inc. | Method and device for the release of drugs to the skin |
JPH0725669B2 (ja) * | 1988-12-23 | 1995-03-22 | 日東電工株式会社 | 経皮投与用医薬製剤 |
DE4002281A1 (de) * | 1990-01-26 | 1991-08-01 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit dem wirkstoff tulobuterol |
IT1251469B (it) * | 1991-07-15 | 1995-05-15 | Zambon Spa | Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante. |
JP2753800B2 (ja) * | 1994-04-14 | 1998-05-20 | 日東電工株式会社 | 経皮吸収型製剤 |
JP3604177B2 (ja) * | 1994-09-14 | 2004-12-22 | 日東電工株式会社 | 経皮吸収製剤 |
JPH08295624A (ja) * | 1995-04-26 | 1996-11-12 | Read Chem Kk | プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤 |
JP3930984B2 (ja) * | 1997-12-12 | 2007-06-13 | 日東電工株式会社 | 経皮吸収型製剤 |
-
1998
- 1998-10-26 JP JP30449898A patent/JP3930984B2/ja not_active Expired - Lifetime
- 1998-12-02 US US09/203,749 patent/US6117447A/en not_active Expired - Lifetime
- 1998-12-08 PT PT98123314T patent/PT922453E/pt unknown
- 1998-12-08 ES ES98123314T patent/ES2246062T3/es not_active Expired - Lifetime
- 1998-12-08 DK DK98123314T patent/DK0922453T3/da active
- 1998-12-08 DE DE69831785T patent/DE69831785T2/de not_active Expired - Lifetime
- 1998-12-08 EP EP98123314A patent/EP0922453B1/en not_active Expired - Lifetime
- 1998-12-08 AT AT98123314T patent/ATE305775T1/de active
- 1998-12-10 CA CA002255447A patent/CA2255447C/en not_active Expired - Fee Related
- 1998-12-10 PL PL330212A patent/PL194195B1/pl unknown
- 1998-12-11 HU HU9802889A patent/HU227974B1/hu not_active IP Right Cessation
- 1998-12-11 BR BRPI9806470-3A patent/BR9806470B1/pt not_active IP Right Cessation
- 1998-12-11 KR KR1019980054329A patent/KR100610185B1/ko not_active IP Right Cessation
- 1998-12-12 CN CN98126197A patent/CN1129426C/zh not_active Expired - Lifetime
-
2000
- 2000-02-22 HK HK00101059A patent/HK1022091A1/xx not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101014074B1 (ko) * | 1999-10-16 | 2011-02-14 | 에르테에스 로만 테라피-시스테메 아게 | 기관지확장제 튜로부테롤의 경피투여를 위한 튜로부테롤 염산염을 함유하는 경피 치료 시스템 |
KR100439659B1 (ko) * | 2001-06-23 | 2004-07-12 | 제일약품주식회사 | 툴로부테롤을 함유하는 경피흡수용 패취제 |
KR100535302B1 (ko) * | 2002-02-01 | 2005-12-08 | 주식회사 태평양 | 툴로부테롤 함유 경피흡수형 제제 |
KR100956023B1 (ko) * | 2007-09-28 | 2010-05-06 | 대화제약 주식회사 | 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제 |
KR20110109995A (ko) * | 2010-03-30 | 2011-10-06 | 닛토덴코 가부시키가이샤 | 패치 제제 및 이의 제조 방법 |
Also Published As
Publication number | Publication date |
---|---|
KR100610185B1 (ko) | 2006-11-30 |
US6117447A (en) | 2000-09-12 |
JP3930984B2 (ja) | 2007-06-13 |
PL330212A1 (en) | 1999-06-21 |
HU9802889D0 (en) | 1999-02-01 |
PL194195B1 (pl) | 2007-05-31 |
DK0922453T3 (da) | 2005-11-07 |
DE69831785T2 (de) | 2006-07-13 |
HU227974B1 (en) | 2012-07-30 |
ATE305775T1 (de) | 2005-10-15 |
EP0922453A3 (en) | 1999-11-24 |
EP0922453A2 (en) | 1999-06-16 |
HK1022091A1 (en) | 2000-07-28 |
ES2246062T3 (es) | 2006-02-01 |
HUP9802889A2 (hu) | 1999-06-28 |
CN1226422A (zh) | 1999-08-25 |
EP0922453B1 (en) | 2005-10-05 |
PT922453E (pt) | 2005-11-30 |
CA2255447A1 (en) | 1999-06-12 |
BR9806470B1 (pt) | 2012-03-20 |
CA2255447C (en) | 2006-01-24 |
BR9806470A (pt) | 2000-04-11 |
CN1129426C (zh) | 2003-12-03 |
JPH11228395A (ja) | 1999-08-24 |
HUP9802889A3 (en) | 2001-04-28 |
DE69831785D1 (de) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100610185B1 (ko) | 경피흡수형제제 | |
JP5084496B2 (ja) | 経皮吸収貼付剤 | |
WO2009139411A1 (ja) | パロノセトロンを含有する経皮吸収製剤 | |
JP2753800B2 (ja) | 経皮吸収型製剤 | |
JP2572763B2 (ja) | エトフェナマ−ト含有貼付薬 | |
KR20180054833A (ko) | 첩부제 | |
JPH0499720A (ja) | 経皮投与用医薬製剤 | |
AU727257B2 (en) | Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties | |
WO2007069661A1 (ja) | ビソプロロール含有貼付製剤 | |
KR980008221A (ko) | 부프레노르핀 경피 흡수 제제 | |
WO2007077741A1 (ja) | 経皮吸収型製剤 | |
JP5584379B2 (ja) | 経皮吸収促進剤、及びそれを含む貼付剤 | |
WO2004019930A1 (ja) | 貼付剤 | |
JP3184474B2 (ja) | 経皮吸収製剤 | |
JP3980634B2 (ja) | 活性物質モルフィン−6−グルクロニドを含む全身的経皮投与用医薬組成物 | |
JPH09268123A (ja) | 局所麻酔用貼付剤 | |
JP4792406B2 (ja) | 経皮吸収型製剤 | |
JP6864968B2 (ja) | 貼付剤 | |
WO2018052039A1 (ja) | 貼付剤 | |
JPH07126157A (ja) | 経皮吸収貼付剤 | |
JP2011126908A (ja) | 経皮吸収型製剤 | |
WO2021192270A1 (ja) | 含水系貼付剤 | |
JP5351756B2 (ja) | 経皮吸収型製剤 | |
JPH1149669A (ja) | 抗ウイルス剤含有テープ製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20050211 Effective date: 20060427 Free format text: TRIAL NUMBER: 2005101000824; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20050211 Effective date: 20060427 |
|
S901 | Examination by remand of revocation | ||
GRNO | Decision to grant (after opposition) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120724 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130719 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140721 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160630 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170720 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180717 Year of fee payment: 13 |
|
EXPY | Expiration of term |